Heparanase is involved in proliferation and invasion of ovarian cancer cells

被引:13
作者
Zheng, Haiyan [1 ]
Ruan, Jian [2 ]
Zhao, Peng [3 ]
Chen, Shiping [1 ]
Pan, Linglan [1 ]
Liu, Jianqiao [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 3, Inst Gynecol & Obstet, Guangzhou 510315, Guangdong, Peoples R China
[2] Southern Med Univ, Tradit Chinese Med Integrated Hosp, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Ovarian cancer; heparanase; invasion; proliferation; EXTRACELLULAR-MATRIX; SULFATE; ANGIOGENESIS; METASTASIS; EXPRESSION; PROTEOGLYCANS; DEGRADATION; PROGRESSION; INHIBITOR; PROMOTES;
D O I
10.3233/CBM-150459
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Heparanase(HPSE), an endo-beta-D-glucuronidase, is found overexpressed in Ovarian cancer (OC). The purpose of our work was to investigate primitively the possible role of HPSE in the development of OC. In this study, RNA interference (RNAi) with a HPSE small hairpin RNAs(HPSE-shRNA) and plasmid with HPSE were used to identify the effects of HPSE on the regulation of malignant behaviors of OC. OV-90 and SKOV3 were selected as a cell model in vitro and in vivo. The results showed that down-regulation of HPSE can significantly inhibit the proliferative and invasive ability of SKOV3 cells, and upregulation of HPSE in OV-90 cells showed the opposite effects. Compared with the parental OC cells, HPSE silencing cells exhibited attenuated capacities in developing tumor in nude mice, while the growth tumors xenografts derived from these cells were dramatically regressed. In conclusion, our results suggest that HPSE contributes to the proliferation and metastasis of OC and HPSE might be a potent molecular target for OC treatment.
引用
收藏
页码:525 / 534
页数:10
相关论文
共 30 条
[1]  
[Anonymous], 2014, Lancet
[2]   Heparan sulphate proteoglycans fine-tune mammalian physiology [J].
Bishop, Joseph R. ;
Schuksz, Manuela ;
Esko, Jeffrey D. .
NATURE, 2007, 446 (7139) :1030-1037
[3]   Heparanase promotes growth, angiogenesis and survival of primary breast tumors [J].
Cohen, I ;
Pappo, O ;
Elkin, M ;
San, T ;
Bar-Shavit, R ;
Hazan, R ;
Peretz, T ;
Vlodavsky, I ;
Abramovitch, R .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (07) :1609-1617
[4]   The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches [J].
De Luca, Antonella ;
Maiello, Monica R. ;
D'Alessio, Amelia ;
Pergameno, Maria ;
Normanno, Nicola .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 :S17-S27
[5]   Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence [J].
Doviner, Victoria ;
Maly, Bella ;
Kaplan, Victoria ;
Gingis-Velitski, Svetlana ;
Ilan, Neta ;
Vlodavsky, Israel ;
Sherman, Yoav .
MODERN PATHOLOGY, 2006, 19 (06) :878-888
[6]   Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis [J].
Edovitsky, E ;
Elkin, M ;
Zcharia, E ;
Peretz, T ;
Vlodavsky, I .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (16) :1219-1230
[7]   Heparanase as mediator of angiogenesis: mode of action [J].
Elkin, M ;
Ilan, N ;
Ishai-Michaeli, R ;
Friedmann, Y ;
Papo, O ;
Pecker, I ;
Vlodavsky, I .
FASEB JOURNAL, 2001, 15 (07) :1661-+
[8]   Small RNAs Targeting Transcription Start Site Induce Heparanase Silencing through Interference with Transcription Initiation in Human Cancer Cells [J].
Jiang, Guosong ;
Zheng, Liduan ;
Pu, Jiarui ;
Mei, Hong ;
Zhao, Jun ;
Huang, Kai ;
Zeng, Fuqing ;
Tong, Qiangsong .
PLOS ONE, 2012, 7 (02)
[9]   A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer [J].
Joyce, JA ;
Freeman, C ;
Meyer-Morse, N ;
Parish, CR ;
Hanahan, D .
ONCOGENE, 2005, 24 (25) :4037-4051
[10]   Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88) [J].
Karoli, T ;
Liu, LG ;
Fairweather, JK ;
Hammond, E ;
Li, CP ;
Cochran, S ;
Bergefall, M ;
Trybala, E ;
Addison, RS ;
Ferro, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (26) :8229-8236